Neurology
doi: 10.25005/2074-0581-2022-24-4-442-451
NEUROPSYCHOLOGICAL PROFILE IN PATIENTS WITH HYPERTENSIVE ENCEPHALOPATHY IN THE BACKGROUND OF RESISTANT ARTERIAL HYPERTENSION

KH.YO. Sharipova1, F.N. Abdulloev2, R.G. Sokhibov3, D.D. Rakhimov1, R.M. Gulova1, G.M. Negmatov4

1Department of Propaedeutics of Internal Diseases, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
2City Medical Center № 2 named after Academician K.T. Tadzhiev, Dushanbe, Republic of Tajikistan
3Department of Internal Diseases № 2, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
4Department of Internal Diseases № 1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan

Objective: To assess the severity of CI in relation to the level of RDR to antihypertensive therapy in patients with primary arterial hypertension (AH) and the features of CI on the background of RAH.

Methods: A complex of modern clinical, hemodynamic and neuropsychological methods was used to assess RDR to treatment and the severity of CI in groups of patients with high and very high RDR to treatment: the group I – with controlled arterial hypertension (CAH; n=40), the group II – with RAH (n=35).

Results: When screening for CI on the Montreal Cognitive Assessment (MoCA) scale, a decrease in the average number of various domains of cognitive function in patients with CAH was found against the background of increased RDR to treatment compared with RAH. The results of the neurodynamic analysis of cognitive function in the Trail Making Test (TMT) indicate the relative sustain of selective attention and information processing speed. However, the established increase in the difference between the part B and part A performance in patients with AH demonstrated a decline in flexible thinking, cognitive control, and programming. The results of the study of regulatory functions showed that frontal dysfunction was observed more often in patients of group II, although the difference was statistically insignificant (p>0.05). Based on the results of speech studies, along with the results of memory impairment testing in the Clock Drawing (CDT) and Free and Cued Selective Reminding – Immediate Recall (FCSRT-IR) tests, a more pronounced decline of semantic memory was found in patients with RAH, indicating the possibility of memory impairment not only due to secondary neurodynamic changes but also due to the neurodegenerative processes.

Conclusion: A significant decrease in semantic memory in patients with RAH suggests the possibility of the transformation of cerebral vascular lesions into neurodegenerative ones or their combination.

Keywords: Neuropsychological profile, cognitive impairment, hypertensive encephalopathy, risk of developing resistance to treatment, resistant arterial hypertension.

Download file:

References
  1. Khamidov NKh, Umarova SA, Sharopova NM. Strukturno-funktsional'noe sostoyanie miokarda u bol'nykh izolirovannoy sistolicheskoy gipertoniey pozhilogo vozrasta s komorbidnoy depressiey [Structural and functional state of myocardium in patients with isolated systolic hypertension of elderly with co-morbid depression]. Zdravookhranenie Tadzhikistana. 2014;4:61-8.
  2. Gurov AN, Katuntseva NA. Uroven' zabolevaemosti tserebrovaskulyarnymi riskami, letal'nosti i smertnosti v Moskovskoy oblasti v 2014 g [The incidence of cerebrovascular diseases, mortality and mortality in the Moscow region in 2014]. Al'manakh klinicheskoy meditsiny. 2015;39(2):11-4.
  3. Maksimova TM, Lushkina NP, Alekseeva NYu, Lomakina EA, Saurina OS, Telnova EA. Otsenka medikamentoznoy terapii pri lechenii arterial'noy gipertonii v statsionare [The evaluation of medicinal therapy under treatment of arterial hypertension in hospital]. Problemy sotsial'noy gigieny, zdravookhraneniya i istorii meditsiny. 2015;23(1):14-8.
  4. Ruziev OA, Ochilova DA. Osobennosti techeniya arterial'noy gipertonii u bol'nykh s dislipidemiey [Features of the course of the arterial hypertension at patients with dislipidemia]. Biologiya i integrativnaya meditsina. 2017;7:66-76
  5. Berkinbaev SF, Dzhunusbekova GA, Musagalieva AT, Koshumbaeva KM, Isabekova AKh, Akpanova DM, i dr. Rasprostranyonnost' osnovnykh serdechno-sosudistykh zabolevaniy sredi zhiteley goroda Almaty [Prevalence of major cardiovascular diseases among Almaty residents]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski. 2017;1(1):52-6.
  6. Rakhmonov RA, Isoeva MB, Kosimova DU, Ganieva MT. Arterial'naya gipertoniya – faktor riska narusheniy mozgovogo krovoobrashcheniya [Arterial hypertension: Risk factor in violations of cerebral circulation]. Vestnik Akademii meditsinskikh nauk Tadzhikistana. 2018;8(1):124-30.
  7. Shalnova SA, Deev AD. Tendentsii smertnosti v Rossii v nachale XXI veka (po dannym ofitsial'noy statistiki) [Mortality trends in Russia at the beginning of the 21st century (according to official statistics)]. Kardiovaskulyarnaya terapiya i profilaktika. 2011;10(6):5-10.
  8. Parfyonov VA. Sovremennye aspekty diagnostiki i lecheniya khronicheskoy ishemii golovnogo mozga (primenenie naftidrofurila) [Modern aspects of diagnosis and treatment of chronic cerebral ischemia (the use of naftidrofuril]. Meditsinskiy sovet. 2015;18:11-6.
  9. Saprygina LV, Belova LA, Mashin VV, Tarakanova OA, Travina IV. Kliniko-epidemiologicheskie kharakteristiki sosudistykh zabolevaniy mozga i ikh faktorov riska u lits trudosposobnogo vozrasta [Clinical and epidemiological characteristics of cerebrovascular diseases and their risk factors in people of working age]. Ul'yanovskiy mediko-biologicheskiy zhurnal. 2014;1:63-7.
  10. Stakhovskaya LV, Klyuchikhina OA, Bogatyryova MD, Kovalenko VV. Epidemiologiya insul'ta v Rossii po rezul'tatam territorial'no-populyatsionnogo registra (2009-2010 gg) [Epidemiology of stroke in Russia based on the results of the territorial population register (2009-2010)]. Zhurnal nevrologii i psikhiatrii. 2013;5:4-10.
  11. Suslina ZA, Varakin YuYa. Klinicheskoe rukovodstvo po ranney diagnostike, lecheniyu i profilaktike sosudistykh zabolevaniy golovnogo mozga [Clinical guide for early diagnosis, treatment and prevention of cerebrovascular diseases]. Moscow, RF: MEDpress-inform; 2015. 440 p.
  12. Gusev EI, Bogolepova AN. Kognitivnye narusheniya pri tserebrovaskulyarnykh zabolevaniyakh [Cognitive impairment in cerebrovascular diseases]. Moscow, RF: MEDpress-inform; 2013. 176 p.
  13. Shlyakhto EV. Rekomendatsii po vyyavleniyu bol'nykh s arterial'noy gipertenziyey [Recommendations for the treatment of patients with arterial hypertension]. Rossiyskiy kardiologicheskiy zhurnal. 2018;12:143-228.
  14. Vakhnina NV. Differentsial'nyy diagnoz nevrologicheskogo zabolevaniya u bol'nykh arterial'noy gipertenziyey [Differential diagnosis of neurological disorders in patients with arterial hypertension]. Consilium Medicum. 2016;18(2):112-117.
  15. Zhivolupov SA, Samartsev IN. Sovremennyy klinicheskiy analiz tserebrovaskulyarnykh zabolevaniy: uzlovye voprosy differentsial'noy diagnostiki i patogeneticheskogo lecheniya [Modern clinical analysis of cerebrovascular diseases: Key issues of differential diagnosis and pathogenetic treatment.]. Farmateka. 2012;7:93-100.
  16. Levin OS. Sovremennye podkhody k diagnostike smeshannoy dementsii [Modern approaches to the diagnosis and treatment of mixed dementia]. Trudnyy patsient. 2014;12(5):40-6.
  17. Gupta AK, Nasothimiou EG, Chang CL, Sever PS, Dahlöf B, Poulter NR. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): А risk score to identify those at high-risk. J Hypertens. 2011;29(10):2004-13.
  18. Tanner RM, Calhoun DA, Bell EK, Bowling CB, Gutiérrez OM, Irvin MR, et al. Prevalence of apparent treatment-resistant hypertension among individuals with CKD. Clin J Am Soc Nephrol. 2013;8(9):1583-90. Available from: https:// doi.org/10.2215/CJN.00550113
  19. Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, et al. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013;62:691-7. Available from: https://doi.org/10.1161/ HYPERTENSIONAHA.113.01448
  20. Konradi AO. Konservativnaya lekarstvennaya terapiya patsientov s rezistentnoy arterial’noy gipertenziey – vremya kompromissa [Conservative drug therapy for resistant hypertension patients – a time for compromise]. Meditsinskiy sovet. 2013;9(1):17-25.
  21. Fagard RKH. Resistant hypertension. Heart. 2012;98:254-61
  22. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635-42. Available from: https://doi.org/10.1161/ CIRCULATIONAHA.111.068064
  23. Parfyonov VA, Zakharov VV, Preobrazhenskaya IS. Kognitivnye rasstroystva [Cognitive disorders]. Moscow, RF: OOO «Gruppa remedium»; 2014. 187 p.
  24. Preobrazhenskaya IS, Yakhno NN. Sosudistye kognitivnye narusheniya: klinicheskie proyavleniya, diagnostika, lechenie [Vascular cognitive impairment: Clinical manifestations, diagnosis, treatment]. Nevrologicheskiy zhurnal. 2007;12(5):45-50.
  25. Skoog I, Lernfelt B, Landahl S. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347(9009):1141-5.
  26. Vakhnina NV, Milovanova OV, Grinyuk VV. Nevrologicheskie rasstroystva u bol'nykh arterial'noy gipertenziey [Neurological disorders in patients with arterial hypertension]. Nevrologiya, neyropsikhiatriya, psikhosomatika. 2015;7(4):57-64. https://doi.org/10.14412/2074-2711-2015-4-57-64
  27. Snowdon DA, Greiner LH, Mortimer JA. Brain infarction and the clinical expression of Alzheimer's disease. JAMA. 1997;277(10):813-7.
  28. Mkhitaryan EA, Preobrazhenskaya IS. Bolezn' Al'tsgeymera i tserebrovaskulyarnye rasstroystva [Alzheimer's disease and cerebrovascular disorders]. Nevrologicheskiy zhurnal. 2006;(Prilozhenie 1):4-12.
  29. Yakhno NN, Preobrazhenskaya IS, Zakharov VV. Rasprostranyonnost' kognitivnykh narusheniy pri nevrologicheskikh zabolevaniyakh (analiz raboty spetsializirovannogo ambulatornogo priyoma) [The prevalence of cognitive impairment in neurological diseases (analysis of the work of a specialized outpatient appointment)]. Nevrologiya, neyropsikhiatriya, psikhosomatika. 2012;2:30-5.

Authors' information:

Sharipova Khursand Yodgorovna
Doctor of Medical Sciences, Full Professor, Professor of the Department of Propaedeutics of Internal Diseases, Avicenna Tajik State Medical University
ORCID ID: 0000-0001-9340-5215
SPIN: 5685-9944
Author ID: 846918
E-mail: sharipovakh@mail.ru

Abdulloev Firdavs Nazirovich
Resident of the Department of Neurology, City Medical Center № 2 named after Academician K.T. Tadzhiev
ORCID ID: 0000-0001-8622-9831
E-mail: abduloevfirdavs01@gmail.com

Sokhibov Rakhmatullo Gulomovich
Candidate of Medical Sciences, Head of the Department of Internal Diseases № 2, Avicenna Tajik State Medical University
ORCID ID: 0000-0002-2413-9299
E-mail: rahmatulosokhibovgmail.com

Rakhimov Dzhasur Dzhumaboevich
Postgraduate Student of the Department of Propaedeutics of Internal Diseases, Avicenna Tajik State Medical University
ORCID ID: 0000-0003-3376-1722
E-mail: jasur5000@yandex.ru

Gulova Rukhshona Makhmadshoevna
Postgraduate Student of the Department of Propaedeutics of Internal Diseases, Avicenna Tajik State Medical University
ORCID ID: 0000-0002-4695-223X
E-mail: komron909@mail.ru

Negmatova Gulnora Mansurovna
Candidate of Medical Sciences, Assistant of the Department of Internal Diseases № 1, Avicenna Tajik State Medical University
ORCID ID: 0000-0002-8309-3999
E-mail: gulya3663@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:

Sharipova Khursand Yodgorovna
Doctor of Medical Sciences, Full Professor, Professor of the Department of Propaedeutics of Internal Diseases, Avicenna Tajik State Medical University

734003, Republic of Tajikistan, Dushanbe, Rudaki Ave., 139

Tel.: +992 (935) 811297

E-mail: sharipovakh@mail.ru

Materials on the topic:
  1. NEUROPHYSIOLOGICAL AND NEURORADIOLOGICAL CHARACTERISTICS OF CHILDREN WITH HEMIPLEGIC CEREBRAL PALSY WITH REGARD TO GENDER AND LATERALITY OF HEMIPARESIS
  2. NON-MOTOR SYMPTOMS OF PARKINSON DISEASE
  3. ASSESSMENT OF COGNITIVE STATUS IN PATIENTS WITH AKINETIC-RIGID AND TREMOR-DOMINANT PARKINSON’S DISEASE
  4. STRATEGY OF DIFFERENTIATED MULTI-STAGE THERAPY OF PROXIMAL SPINAL AMIOTROPHY IN CHILDREN
  5. EPIDEMIOLOGY OF STROKE IN THE GISSAR REGION OF TAJIKISTAN
  6. COGNITIVE DYSFUNCTIONS IN PATIENTS OF MIDDLE, ELDERLY AND OLD AGE IN THE LONG-TERM PERIOD AFTER CHOLECYSTECTOMY
  7. TOTAL CARDIOVASCULAR RISK – A NEW APPROACH FOR PREDICTING STROKE
  8. EXPERIENCE OF CLINICAL APPLICATION OF THE METHOD OF INTEGRATED GRAPHIC GEOMETRICAL LOGARITHMIC EVALUATION OF COGNITIVE FUNCTIONS

◄ Back to the list